advertisement

Topcon

11.5.2 Topical (11)

Showing records 1 to 11

Display all abstracts in classification 11.5.2 Topical

Search within classification 11.5.2 Topical
86436 An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Supuran CT
Expert Opinion on Drug Metabolism and Toxicology 2020; 16: 297-307
86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Schmickl CN
BMJ open respiratory research 2020; 7:
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Li T
Drug Delivery 2020; 27: 410-421
86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Owens RL
BMJ open respiratory research 2020; 7:
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Wang Y
Drug Delivery 2020; 27: 410-421
86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Orr JE
BMJ open respiratory research 2020; 7:
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Chen J; Gao X
Drug Delivery 2020; 27: 410-421
86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Edwards BA
BMJ open respiratory research 2020; 7:
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Pan S
Drug Delivery 2020; 27: 410-421
86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Malhotra A
BMJ open respiratory research 2020; 7:
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Su Y; Zhou X
Drug Delivery 2020; 27: 410-421

Issue 21-2

Change Issue


advertisement

Oculus